Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase

被引:31
|
作者
Daeubener, Walter
Schmidt, Silvia K.
Heseler, Kathrin
Spekker, Katrin H.
MacKenzie, Colin R.
机构
[1] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany
关键词
Endothelial cells; inducible nitric oxide synthase; indoleamine 2,3-dioxygenase; interferon-gamma; effector mechanisms; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; HUMAN CYTOMEGALOVIRUS; TOXOPLASMA-GONDII; TRYPTOPHAN CATABOLISM; STAPHYLOCOCCUS-AUREUS; IFN-GAMMA; EXPRESSION; INHIBITION; ACTIVATION;
D O I
10.1160/TH09-04-0250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In infectious diseases, interferon-gamma (IFN-gamma) is generally accepted as one of the most important inducers of antimicrobial and immunoregulatory effects, and both seemingly contradictory effects, can be mediated by the same effector molecules. In detail,several IFN-gamma induced enzymes such as the inducible nitric oxide synthase (iNOS) as well as the indoleamine 2,3-dioxygenase (IDO) also exert this double function. In this review we focus on antimicrobial and immunoregulatory properties of both enzymes expressed by human endothelial cells, which are prominent players in infectious diseases, tumour immunology and transplant medicine.
引用
收藏
页码:1110 / 1116
页数:7
相关论文
共 50 条
  • [21] Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
    Weber, Benjamin
    Nickel, Elena
    Horn, Michael
    Nienhaus, Karin
    Nienhaus, G. Ulrich
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2014, 5 (04): : 756 - 761
  • [22] Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
    Curti, A.
    Aluigi, M.
    Pandolfi, S.
    Ferri, E.
    Isidori, A.
    Salvestrini, V.
    Durelli, I.
    Horenstein, A. L.
    Fiore, F.
    Massaia, M.
    Piccioli, M.
    Pileri, S. A.
    Zavatto, E.
    D'Addio, A.
    Baccarani, M.
    Lemoli, R. M.
    LEUKEMIA, 2007, 21 (02) : 353 - 355
  • [24] Redox regulation of the critical immunoregulatory enzyme indoleamine 2,3-dioxygenase 1
    Yeung, A. W. S.
    Lim, Y. J.
    Glaros, E.
    Hastad, M.
    Dang, L.
    Freewan, M.
    Orfi, L.
    Keri, G.
    Szabadkai, I
    Terentis, A. C.
    King, N. J. C.
    Witting, P. K.
    Thomas, S. R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 712 - 712
  • [25] Ferryl Derivatives of Human Indoleamine 2,3-Dioxygenase
    Lu, Changyuan
    Yeh, Syun-Ru
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (24) : 21220 - 21230
  • [26] Substrate Stereoselectivity of Human Indoleamine 2,3-Dioxygenase
    Lewis-Ballester, Ariel
    Yeh, Syun-Ru
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 438A - 438A
  • [27] Crystal Structure of Human Indoleamine 2,3-dioxygenase
    Sugimoto, Hiroshi
    Oda, Shun-ichiro
    Otsuki, Takashi
    Yoshida, Tadashi
    Shiro, Yoshitsugu
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C215 - C215
  • [28] The role of serine 167 in human indoleamine 2,3-dioxygenase: A comparison with tryptophan 2,3-dioxygenase
    Chauhan, Nishma
    Basran, Jaswir
    Efimov, Igor
    Svistunenko, Dimitri A.
    Seward, Harriet E.
    Moody, Peter C. E.
    Raven, Emma Lloyd
    BIOCHEMISTRY, 2008, 47 (16) : 4761 - 4769
  • [29] INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION IN HUMAN MENINGIOMAS
    Zitron, Ian M.
    Juhasz, Csaba
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2010, 12 : 32 - 32
  • [30] Distribution of Indoleamine 2,3-dioxygenase in the human placenta
    Nosaka, Suguru
    Hirata, Eiji
    Miyoshi, Hiroshi
    Kudo, Yoshiki
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2015, 112 : 136 - 136